News & Articles

Leading medical institution in India purchases Feedback plc’s image texture analysis technology

Learn how a lab in the US is using cell culture methods to enhance the effectiveness of virus-like particles (VLPs) as novel vaccines against filoviruses

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23

How understanding the mechanisms involved in cellular aging and degeneration can help accelerate drug discovery

How cross-functional collaboration between academia and industry is advancing drug discovery in the ULTRA-DD program

ZEISS ZEN Connect provides information from all dimensions of a sample

Improved optical sectioning delivers higher resolution without the need to acquire a z-stack

A case for single cell isolation

To be in with a chance of winning a $500/£400/450€ Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your lab in 2017

The new ImageXpress Pico system offers cellular imaging acquisition and at an affordable price point

Discover 10 wonderful webinars popular with scientists across the globe in 2017 — and watch them on demand

PRIMA, miniaturized wireless photovoltaic sub-retinal implant, elicited visual perception in the first human subject with Atrophic Dry-AMD

Which new product, instrument or consumable has made the most difference to your lab? Nominate now for a chance to win a $500 Amazon voucher

SelectScience celebrates scientists at the forefront of cancer research, from liquid biopsies through cancer stem cells to drug delivery innovations

SelectScience is attending SLAS 2018 in San Diego, USA, where we will host the Scientists’ Choice Awards for Drug Discovery at our special 20th Anniversary Party

Salk researchers identify the molecular target of J147, which is nearing clinical trials to treat Alzheimer’s disease

Learn how a lab in the US has perfected a high-throughput assay in mouse organoids for testing potential new cystic fibrosis drugs

Smokers may be predisposed to their habit because of the molecular make-up of their brain, research suggests.

Drug delivery researcher, Dr. Maria Lambros, describes her goal to exclusively target pancreatic cancer cells with chemotherapy drugs, while keeping healthy cells unaffected